Intermediate Grade Lung Neuroendocrine Neoplasm
2 clinical trials · Condition
◉ Watch Intermediate Grade Lung Neuroendocrine Neoplasm
| Record | Firm | Date |
|---|---|---|
| Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin (NCT02420691) | M.D. Anderson Cancer Center | 2015-08-25 |
Track Intermediate Grade Lung Neuroendocrine Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.